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Lipoproteins are protein–lipid nanoparticles that transport lipids in circulation and are central in
atherosclerosis and other disorders of lipid metabolism. Apolipoproteins form ﬂexible structural
scaffolds and important functional ligands on the particle surface and direct lipoprotein metabo-
lism. Lipoproteins undergo multiple rounds of metabolic remodeling that is crucial to lipid trans-
port. Important aspects of this remodeling, including apolipoprotein dissociation and particle
fusion, are mimicked in thermal or chemical denaturation and are modulated by free energy barri-
ers. Here we review the biophysical studies that revealed the kinetic mechanism of lipoprotein sta-
bilization and unraveled its structural basis. The main focus is on high-density lipoprotein (HDL). An
inverse correlation between stability and functions of various HDLs in cholesterol transport suggests
the functional role of structural disorder. A mechanism for the conformational adaptation of the
major HDL proteins, apoA-I and apoA-II, to the increasing lipid load is proposed. Together, these
studies help understand why HDL forms discrete subclasses separated by kinetic barriers, which
have distinct composition, conformation and functional properties. Understanding these properties
may help improve HDL quality and develop novel therapies for cardiovascular disease.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction are found in most amyloid deposits in vivo [6–8]. Apolipoprotein1.1. Lipoproteins are dynamic vehicles for lipid transport
Lipids in the body are transported via lipoproteins that are
non-covalent dynamic assemblies of speciﬁc proteins, termed
apolipoproteins (apos), and lipids. Lipoproteins vary in size (101–
102 nm), density, composition, structure and function. Plasma
lipoproteins are central to cardiovascular health and disease
[1,2]; this disease remains the leading cause of death in the
developed countries [3]. Lipoproteins are also central to other
major disorders of lipid metabolism such as metabolic syndrome,
obesity and diabetes II [1,2], whereas apoE, which is the main
apolipoprotein in the brain [4], acts in an isoform-speciﬁc manner
as a major genetic risk factor for Alzheimer’s disease [5]. Moreover,
apolipoproteins are prone to misfolding and can form ﬁbrils thatmisfolding can cause systemic amyloidoses and has been implicat-
ed in atherosclerosis [6–8]. Both normal functions of apolipopro-
teins and their pathologic misfolding are critically hinged on
their remarkable structural ﬂexibility that enables these amphi-
pathic proteins to adapt their conformations to lipoproteins of var-
ious sizes and to the aqueous environment such as plasma [9–11].
Apolipoproteins comprise up to 50% of the total lipoprotein
mass and form ﬂexible structural scaffolds and essential functional
ligands on the lipoprotein surface [11,12]. These proteins direct
lipoprotein metabolism by activating lipophilic enzymes, interact-
ing with lipid transfer proteins, and binding and activating lipopro-
tein receptors [11,12]. Each lipoprotein particle contains several
apolipoproteins and hundreds of lipids. The particle surface is com-
prised of apolipoproteins embedded into a monolayer of polar
lipids, mainly phospholipids and cholesterol. The polar moieties
of the proteins and lipids face solvent and thereby confer lipopro-
tein solubility, while the apolar lipids (mainly cholesterol esters
and triacylglycerides, or fat) are sequestered in the core (Fig. 1
below). This assembly helps solubilize lipids and transport them
to and from peripheral cells in the aqueous environment of plasma,
lymph and cerebrospinal ﬂuid.
Lipoproteins form major classes differing in the particle
size, density, biochemical composition and function: high-, low-,
Fig. 1. Reverse cholesterol transport in a nut shell. Cartoon illustrates selected steps in this complex process. ApoA-I interacts with the plasma membrane and ABCA1
transporter to generate nascent ‘‘discoidal’’ HDL (1). These HDL take up additional cholesterol from the membrane (2) which is esteriﬁed by LCAT. The hydrophobic
cholesterol ester produced in this reaction moves from the HDL surface to its core, leading to HDL maturation and formation of small spherical particles termed HDL3 (3).
These small HDL are further remodeled by LCAT and other plasma factors, such as cholesterol ester transfer protein (CETP) (4). This remodeling can cause imbalance between
the polar surface and the apolar core of the particle, leading to partial protein dissociation and lipoprotein fusion to form larger HDL2 (5). Large lipid-loaded HDL2 form
preferential substrates for the scavenger receptor, SR-BI, that mediates uptake of apolar core lipids and HDL disintegration (6). The dissociated apoA-I is either recycled or gets
degraded or misfolded. Figure modiﬁed from [61].
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VLDL) and chylomicrons [11–14]. Since proteins, which are heavier
than lipids, are located on the particle surface, the particle dia-
meter increases with decreasing density, from high-density
lipoprotein (HDL) (7–12 nm) and low-density lipoprotein (LDL)
(20–24 nm) to very low-density lipoprotein (VLDL) (40–100 nm).
Each lipoprotein class has speciﬁc functions in lipid transport.
HDLs remove excess cholesterol from peripheral cells, such as arte-
rial macrophages, and have other beneﬁcial properties. Plasma
levels of HDL cholesterol (‘‘good cholesterol’’) and the major HDL
protein, apoA-I (28kDa), have long been known to correlate
inversely with the risk of cardiovascular disease [14–16]. In con-
trast, LDL, which is the major plasma carrier of cholesterol in the
form of cholesterol ester, delivers it to the peripheral tissues. The
plasma levels of LDL cholesterol (‘‘bad cholesterol’’) and the major
LDL protein, apoB (550kDa), are the main causative risk factors of
atherosclerosis [1,2,13,16]. VLDL, which is the main plasma carrier
of fat, is the metabolic precursor of LDL and a critical risk factor for
metabolic syndrome and diabetes II [1,2,13,17]. Each lipoprotein
class is further subdivided into subclasses with distinct particle
size, biochemical composition, and functional properties [18–20].
Analysis of these properties is the major thrust in the ongoing
efforts to improve lipoprotein functionality and develop novel
diagnostic tools and therapies for cardiovascular disease to com-
plement statins, ﬁbrates and other lipid-lowering drugs [20–22].
Lipoprotein metabolism is an extremely complex process dur-
ing which individual particles exchange their proteins and lipids
and undergo extensive remodeling by lipophilic enzymes, lipid
transfer proteins and lipoprotein receptors. One example of such
remodeling is HDL maturation and growth in reverse cholesterol
transport [23,24]. In this complex pathway, nascent HDLs, which
can be envisioned as ‘‘discoidal’’ particles comprised of a choles-
terol-containing phospholipid bilayer with proteins wrapped
around the perimeter, are transformed into mature ‘‘spheroidal’’
HDLs that contain a core of apolar lipids, mainly cholesterol esters
(Fig. 1). This transformation is driven by lecithin:cholesterol acyl-
transferase (LCAT) that converts polar molecules of cholesterol
and phosphatidylcholine into apolar cholesterol ester and free fattyacid. This and many other remodeling reactions shift the balance
between the polar surface of a lipoprotein and its apolar core.
Below we describe how this balance can be restored upon sponta-
neous lipoprotein fusion, ﬁssion and protein dissociation.
Although over 90% of all apolipoproteins circulate on the
lipoprotein surface in a stable highly a-helical conformation, a
small sub-population is found in a transient lipid-poor or lipid-free
form [24–27], termed ‘‘free’’ for brevity. This structurally labile
metabolically active form can be generated de novo or upon disso-
ciation from the lipoprotein surface. Free apos are rapidly recruited
for binding to plasma membrane or to other lipoproteins (Fig. 1);
alternatively, they are either degraded or misfolded and form amy-
loid [6–8]. Apolipoproteins undergo large conformational changes
in these transitions, from the highly dynamic partially unfolded
free state, to a more stable largely a-helical lipid-bound state, to
intermolecular cross-b-sheet in amyloid.
Lipoprotein heterogeneity and ability to exchange their protein
and lipid constituents raises several fundamental questions. First,
what maintains the overall integrity of the lipoprotein assembly
in the absence of unique speciﬁc packing of its proteins and lipids?
Second, what structural stability is optimal for lipoprotein func-
tions? A related question is: how do apolipoproteins adapt their
conformation to the changing lipid load during lipid transport?
What is the conformational ensemble of an apolipoprotein free in
solution and on the surface of various lipoproteins? Finally, what
makes apolipoproteins amyloidogenic? The answers are beginning
to emerge as a result of decades of work by many research groups.
Here, we review our biophysical studies of lipoproteins, with
the focus on HDLs which are the smallest particles whose struc-
tural and stability properties have been best characterized. First,
we provide a brief overview of HDL metabolism. Next, we outline
the thermodynamic stabilization of lipid-free apolipoproteins in
solution, and contrast it with the kinetic stabilization of model
and plasma HDL. This is followed by the description of the key
determinants for HDL stability and their relevance to HDL func-
tions at speciﬁc steps of cholesterol transport. Finally, we propose
a structure-based mechanism for functional adaptation of HDL
proteins to the increasing lipid load during reverse cholesterol
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can lead to human amyloidosis [8], and the structural stability and
fusion of LDL, which is an early triggering event in atherosclerosis
[28], have been recently reviewed elsewhere.1.2. Functionality of ‘‘good cholesterol’’: quality versus quantity
HDLs and their major protein, apoA-I (28kDa) remove excess
cholesterol from peripheral cells via the reverse cholesterol trans-
port, which is the sole pathway for cholesterol removal from the
body [23,24,29] (Fig. 1). In addition, HDLs possess anti-inﬂamma-
tory, anti thrombolytic, anti-oxidant and other beneﬁcial proper-
ties [14,15,19,20]. Although the inverse correlation between the
risk of cardiovascular disease and the plasma levels of ‘‘good
cholesterol’’ and apoA-I has been known for over 40 years, recent
populational studies and clinical trials revealed that raising the
HDL levels does not necessarily improve cardiovascular health
[30]. Thus, the current consensus is that not all HDLs are created
equal, and that functionality of lipoproteins is no less important
than their steady-state levels [19,30]. This functionality depends
on the protein and lipid composition and conformation, which
determine the dynamic properties of HDL and the overall rate of
cholesterol removal.
To obtain key determinants for HDL function, it is important to
understand the energetic basis for structural stability and remod-
eling of HDL at various steps of cholesterol transport. To this end,
our laboratory has analyzed structural stability of free apos as well
as of reconstituted ‘‘discoidal’’ and plasma ‘‘spherical’’ HDL and
their individual subclasses differing in the particle size, composi-
tion, oxidative status, and other properties. The rationale for these
studies and their representative results are outlined below.2. Structural stability of HDL and its proteins
2.1. Structural ﬂexibility of free apolipoproteins in solution
All HDL apos are water-soluble, or exchangeable. Exchangeable
apos form a conserved family of proteins that have evolved from a
single precursor gene via the duplication or deletion of 11-mer
codon repeats. These repeats encode for tandem 11-residue
sequence repeats with high propensity to form amphipathic a-he-
lices [31]. Class-A a-helices that form the major structural and
functional motif in the apolipoprotein family (A stands for apos)
are distinct from the class-G helices found in globular proteins.
Class-A helices contain a large fraction of apolar residues that con-
fer lipid binding afﬁnity, and a substantial fraction of charged resi-
dues that confer protein solubility. Characteristic radial
distribution of these residues optimizes lipid surface binding.
Large apolar faces in class-A helices, which comprise 30–50% of
the total surface area (as compared to15% typical of globular pro-
teins), form the lipid binding sites [31]. They are ﬂanked by the
basic residues that can contribute to lipid binding via the
hydrophobic interactions with the phospholipid acyl chains and
the electrostatic interactions with the phospholipid head groups.
Acidic residues are located in the middle of the polar helical face
and can form extensive salt links with the basic residues, which
probably contribute to protein stability in solution and on HDL
[32–34]. Thus, in contrast to 7-mer helical repeats found in globu-
lar proteins, apolipoprotein helices are comprised of 11-mer
sequence repeats that are optimized for lipid surface binding.
In lipid-free exchangeable apos in solution, the large apolar
helical faces are involved in protein–protein interactions. These
interactions are apparently less extensive than those in globular
proteins. As a result, the structural stability of most apolipopro-
teins is lower than that of typical globular proteins (under3 kcal/mol for apoA-I and even lower for smaller apos), while their
aggregating propensity is higher. These and other properties of free
apos, including apoA-I, apoA-II, apoC-I and apoE, resemble the
compact molten-globular folding intermediates [9,35–38].
Larger apos such as apoA-I (28kDa) [34] or apoE (43 Da) [5,37]
contain a globular helix-bundle domain in the N-terminal two-
thirds of the protein, and an intrinsically disordered C-terminal
domain that forms the primary lipid binding site. Smaller apos free
in solution are even less well-ordered. For example, lipid-free
apoA-II, a 9kDa protein that forms a disulﬁde-linked homodimer
in humans, has marginally stable a-helical structure at near-
physiologic conditions, which unfolds upon either heating or cool-
ing from 25 C [35]. Another example is apoC-I (6kDa), the smallest
exchangeable apo that is 30% a-helical in solution as a monomer,
acquires additional helical structure upon self-association, and
undergoes unfolding accompanied by oligomer dissociation upon
either heating or cooling from 25 C [36]. Other small apos such
as apoC-II and apoC-III (9kDa) lack stable secondary structure in
solution [5,8]. In sum, these and other free exchangeable apos
are fully or partially intrinsically disordered.
Lipid binding induces helical structure in these proteins and
stabilizes them against proteolyisis and misfolding [38–40].
What is the physical basis for this stabilization? With few excep-
tions, most published studies have been focused on thermodynam-
ic stability of lipoproteins, perhaps because it is easier to access
experimentally. In such studies, the samples are heated and cooled
at a constant rate (in melting experiments), or denaturant concen-
tration is increased incrementally (in titration experiments), and
the resultant structural changes are monitored by calorimetry or
spectroscopy as a function of temperature or denaturant concen-
tration. Although the midpoint of the protein unfolding transition
is often taken as a measure of relative stability, the ultimate goal
is to determine the difference in free energy, DG = GD  GN, or
enthalpy, DH = HD  HN, between the native (N) and the denatured
(D) states. A key assumption is that these two states are in equilib-
rium throughout the transition, i.e. that the denaturation is ther-
modynamically reversible.
Application of the thermodynamic approach to lipoproteins has
one major caveat: lipoproteins are irreversibly disrupted upon
thermal or chemical denaturation. It is well-known that, except
for simple model complexes described in the next section, dena-
tured lipoproteins do not spontaneously re-assemble into their
native state. This irreversibility questions the application of the
conventional thermodynamic approach to the analysis of lipopro-
tein stability and necessitates an alternative kinetic approach [41].
2.2. Model lipoproteins are stabilized by free energy barriers
To address the physical basis for HDL stability, we initially used
complexes reconstituted from a model phospholipid dimyristoyl
phosphatidylcholine (DMPC) and apoC-I (57 a.a.), the smallest
human apolipoprotein that modulates HDL and VLDL metabolism
and is a structural and functional prototype of larger members of
this protein family [36,41]. DMPC (C14:0, C14:0) is a relatively short-
chain fully saturated phospholipid that can spontaneously self-
assemble with apolipoproteins upon incubation at 24 C. The resul-
tant lipoproteins are ‘‘discoidal’’ particles 10–15 nm in diameter, as
suggested by non-denaturing gel electrophoresis and negative
stain electron microscopy (Fig. 2A and B). These lipoproteins pro-
vide a simple experimental model for nascent plasma HDL, which
are comprised mainly of apoA-I, longer-chain PCs, and cholesterol.
Arguably the easiest way to assess macromolecular stability is
through the melting experiments. To this end, apoC-I:DMPC disks,
which have 60% a-helical content at 25 C, were heated and
cooled from 5 to 98 C at a rate of 80 C/h. Circular dichroism
(CD) signal was recorded at 222 nm to monitor a-helical unfolding
Fig. 2. Model discoidal HDL are stabilized by free energy barriers. (A) Lipoproteins reconstituted from a model phospholipid and an apolipoprotein form bilayer ‘‘disks’’ with
protein a-helices wrapped around the perimeter. Heat denaturation kinetics of these particles was monitored in T-jump experiments from 25 C to higher constant
temperatures by CD spectroscopy at 222 nm for a-helical unfolding. Solid lines show single-exponential data ﬁtting that was used to determine k(T) for the Arrhenius
analysis. (B) Negative stain electron microscopy of discoidal HDL before and after heat denaturation. Intact particles are seen as disk stacks; such stacking is characteristic of
negative staining. (C) Cartoon showing intact discoidal lipoproteins, the products of their denaturation, and the proposed high-energy transition state of disk fusion and
protein dissociation.
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experiments were conducted with free monomeric apoC-I that is
30% a-helical at 25 C. Like other free apolipoproteins [9,35,37],
apoC-I in solution undergoes a sigmoidal unfolding that is reversi-
ble upon cooling [36]. The heating and cooling data of free apos are
independent of the scan rate and do not show hysteresis, indicat-
ing a thermodynamically reversible transition.
Compared to free apoC-I whose thermal unfolding was centered
at Tm  55 C, the heat unfolding transition of apoC-I:DMPC disks
shifted to higher temperatures (Tm,app = 72 C at 80 C/h) suggest-
ing increased stability [41]. Moreover, the heating and cooling data
showed a hysteresis, indicating thermodynamic irreversibility. To
test its origin, we slowed down the scan rate to provide more time
for the system to reach equilibrium at each temperature and there-
by try and close the gap between the heating and cooling curves.
CD melting data were collected at several scan rates from 80 to
3 C/h, so the fastest experiment took a couple of hours while the
slowest took a couple of days. Hysteresis was observed at any scan
rate explored, indicating that heat denaturation of apoC-I:DMPC
complexes is inherently thermodynamically irreversible [41].
Importantly, the apparent melting temperature, Tm,app, which
was taken at the inﬂection point in the heating data, decreased
from 72 to 48 C upon slowing down the heating from 80 to 4 C/
h. Therefore, the melting temperature alone cannot be used as a
reliable measure of lipoprotein stability. Moreover, large scan rate
effect on Tm,app indicates high activation energy, Ea. The value esti-
mated from the scan rate effects on the melting data of apoC-
I:DMPC complexes was Ea = 25 ± 5 kcal/mol [41,42].
To verify this value, we conducted kinetic temperature-jump
(T-jump) experiments in which the transition was triggered by a
rapid increase in temperature from 25 C to a high constant value,
and the time course of protein unfolding was monitored by far-UV
CD at 222 nm,H222(t) (Fig. 2A). By the time the ﬁrst data point was
recorded (10 s), free protein was fully unfolded. In contrast, the
unfolding in apoC-I:DMPC complexes proceeded on a much slower
time scale that could be monitored by CD. At each temperature, the
time course of the unfolding was well-approximated by a singleexponential, H222(t) = A exp (kt), which was used to determine
the reaction rate k(T) and obtain an Arrhenius plot, ln k(T) versus
1/T. The slope of this plot corresponded to an activation energy
Ea = 25 ± 5 kcal/mol, verifying the value obtained from the melting
experiments [41,42].
What is the meaning of this value? Arrhenius activation energy,
Ea ﬃ DHv⁄, is the enthalpic component of the free energy barrier that
deﬁnes kinetic stability, DG⁄ = DH⁄  TDS⁄; here ⁄ denotes the
high-energy transition state that is the bottleneck of the reaction,
and D refers to the difference between the transition and the
native states, DG⁄ = G⁄  GN (Fig. 2C). The free energy barrier,
DG⁄, determines the rate k of the lipoprotein denaturation.
According to the transition state theory, DG⁄ = RT ln(k/K), where
k is the observed rate constant and K is the rate constant in the
absence of the barrier. The heat- or denaturant-induced structural
transition in lipoproteins observed in our kinetic experiments
occurred on a time scale of hours (k  103 s1), much slower than
the typical unfolding rate in small helical proteins in solution
(K  108  1010 s1) which, in turn, is slower than the theoretical
‘‘speed limit’’ in Eyring equation (kBT/h  6 * 1012 s1).
Thus, apoC-I binding to DMPC decelerates the unfolding by
more than 10 orders of magnitude, which corresponds to
DG⁄ = 18 ± 2 kcal/mol [41].
This value of kinetic stability is comparable or higher than the
typical thermodynamic stability of globular proteins, and is much
higher than the thermodynamic stability of free apos in solution
under ambient conditions, DG < 3 kcal/mol. This kinetic barrier
helps explain why lipoprotein formation stabilizes apos against
unfolding, misfolding and proteolysis despite the lack of unique
packing interactions in these dynamic assemblies.
2.3. Physical origin of free energy barriers
What is the physical basis for the kinetic stabilization of
lipoproteins? A related question is: what happens to the lipids as
the proteins unfold? The answer requires basic physical under-
standing of the native and the denatured lipoprotein state, as well
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end, we analyzed lipoproteins at various stages of thermal or che-
mical denaturation by using negative stain electron microscopy
(Fig. 2B) and non-denaturing gel electrophoresis. We also recorded
changes in turbidity or in 90 light scattering in CD experiments
[41,43]. This enabled us to simultaneously monitor micro- and
macroscopic changes during lipoprotein heating and cooling, such
as the a-helical unfolding (by far-UV CD) and the changes in the
particle size (by turbidity or light scattering). The results revealed
that lipoprotein denaturation involves a-helical unfolding coupled
to apolipoprotein dissociation and the increase in the particle size
due to fusion [41–44]. The observations that the activation energy
Ea and the free energy barrier DG⁄ increased nearly linearly with
increasing protein size and acyl chain length suggested strongly
that the rate-limiting step in lipoprotein disruption involves disso-
ciation of a lipid-poor protein molecule [44,45]. Other kinetic stud-
ies of apoA-I exchange support this conclusion [27,46,47].
Together, our studies of model lipoproteins have revealed a
molecular basis for kinetic stabilization of discoidal HDL, which
can be summarized as follows. The heat- or denaturant-induced
protein unfolding disrupts the apolar lipid-binding surfaces of
the amphipathic apolipoprotein a-helices and thereby promotes
their dissociation from the lipid [41,44]. Protein dissociation pro-
duces transient hydrophobic packing defects, or sticky patches,
on the lipoprotein surface, which initiate lipoprotein aggregation
and fusion. Lipoprotein fusion reduces surface-to-volume ratio
and thereby compensates for the loss of the polar surface moiety.
Such fusion involves transient disruption of multiple protein–lipidFig. 3. Mature plasma HDL are stabilized by free energy barriers. Thermal or chemical den
(A), negative stain electron microscopy (B), circular dichroism spectroscopy (C) and
transitions, one involving HDL fusion and another HDL rupture and release of apolar core
the proposed high-energy transition state of HDL fusion.and lipid–lipid packing interactions [41,44,45], providing a large
favorable enthalpic contribution DH⁄ ﬃ Ea to the free energy barri-
er DG⁄ = DH⁄  TDS⁄. This barrier deﬁnes the kinetic stability of
discoidal lipoproteins and determines the rate of their remodeling
(Fig. 2C).
2.4. Human plasma HDL is stabilized by free energy barriers
Is structural stability of plasma HDL also modulated by kinetic
barriers? If so, what is the physical origin of these barriers?
Compared to lipoprotein ‘‘nanodisks’’, mature plasma HDL have
more complex structure and biochemical composition: in addition
to the proteins and polar lipids on the surface, they also contain
apolar lipids in the core. Therefore, the free energy landscape of
mature HDL is expected to be more complex, potentially featuring
more than one barrier separating more than two distinct structural
states [48]. This idea is supported by multiple lines of evidence
obtained in calorimetric, electron microscopic, spectroscopic and
biochemical studies [48–51].
For example, differential scanning calorimetry of mature
human plasma HDL shows two high-temperature peaks in the heat
capacity function, Cp(T), which correspond to two irreversible tran-
sitions (Fig. 3A) [49,50]. In comparison, just one high-temperature
calorimetric peak corresponding to fusion is observed in discoidal
lipoproteins [50]. All these transitions shift to lower temperatures
at slower heating rates, indicating kinetic control.
Electron microscopic analysis of HDL at various stages of
thermal denaturation reveals that the ﬁrst high-temperatureaturation of human plasma HDL was monitored by differential scanning calorimetry
non-denaturing gel electrophoresis (D). The results revealed two morphological
lipids. Both transitions involve apolipoprotein dissociation. (E) Cartoon illustrating
Fig. 4. Cartoon illustrating free energy barriers between HDL subclasses. The ﬁgure
is not meant to represent the relative energies of the stable HDL states or the
barriers between them. This dynamic energy landscape depends on the biochemical
composition of HDL that constantly changes, and on the environmental conditions.
Factors that help traverse these barriers by lowering them during reverse
cholesterol transport are indicated: ABCA1 transporter, LCAT, cholesterol ester
and phospholipid transport proteins (CETP and PLTP), hepatic lipase and SR-BI
receptor. Remarkably, thermal, chemical and other perturbations (e.g. by deter-
gents, bacterial factors etc. [46,47,52,53]) induce very similar HDL fusion, rupture
and apolipoprotein dissociation, mimicking key aspects of the morphologic HDL
transitions in vivo. This similarity suggests that HDL remodeling in vivo and in vitro
is modulated by similar kinetic barriers. Figure modiﬁed from [10].
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HDL merge to form a larger HDL-like particle (Fig. 3A and B). The
second calorimetric peak corresponds to HDL rupture, i.e. collapse
of the lipoprotein morphology and release of the apolar core lipids
that coalesce into droplets (Fig. 3A and B). Irreversible increase in
the particle size upon heat-induced HDL fusion and rupture and
the concomitant apolipoprotein unfolding was also observed in
the melting experiments monitored by CD spectroscopy and tur-
bidity or light scattering [32,48–51]. Finally, kinetic experiments
such as temperature- or denaturant-jumps showed a slow two-
phase unfolding kinetics that could be approximated with a dou-
ble-exponential function (Fig. 3C). We proposed that the ﬁrst
kinetic phase reﬂects HDL fusion, while the second phase corre-
sponds to HDL rupture and release of core lipids [32,48]. Both
phases involve dissociation and unfolding of HDL proteins
[32,46,50] (Fig. 3D and E).
This idea agrees with other studies reporting two distinct
populations of apoA-I on HDL: one readily exchangeable and the
other more strongly associated with the particle [52–54]. Studies
using non-denaturing gel electrophoresis and Western blotting
suggest that HDL fusion involves the dissociation of the loosely
bound population of apoA-I and minor apos, while the more
strongly bound population of apoA-I, as well as apoA-II that inserts
deeper into the lipid, stay on the particle until its rupture
[32,44,51].
The activation energy of HDL fusion, which was estimated by
using an Arrhenius analysis of the kinetic data recorded at near-
physiologic salt concentrations and pH, was Ea  50 kcal/mol
[32]. We proposed that this high activation energy arises from
transient disruption of multiple protein–lipid and lipid–lipid
interactions. Such disruption occurs during dissociation of apoA-I
molecule and re-packing of the remaining proteins and lipids from
two-to-three HDL that fuse to form a single particle [48]. Similarly,
fusion in other lipid systems such as cell membranes involves tran-
sient disruption of many packing interactions, leading to high acti-
vation energy of tens of kcal/mol. In HDL, this activation energy
provides an enthalpic contribution to the free energy barrier that
determines the rate of HDL fusion in vitro and in vivo.
2.5. Physiological role of kinetic HDL stability
HDL fusion, rupture and apolipoprotein dissociation observed
upon thermal or chemical denaturation mimic important aspects
of the metabolic HDL remodeling by plasma factors [10,48,52,54].
For example, electron microscopic analysis suggests that heat- or
denaturant-induced HDL fusion resembles metabolic conversion
of smaller denser HDL3 into larger lipid-loaded HDL2 particles
[48,52] (Figs. 3B and D; 4). Such a conversion is thought to occur
during reverse cholesterol transport upon increasing lipid load in
HDL. In fact, HDL remodeling by several plasma factors, such as
LCAT or cholesterol ester and phospholipid transfer proteins, shifts
the balance between the core and surface of HDL, which induces
apoA-I dissociation and HDL fusion [55–58]. Another example is
HDL rupture and release of the apolar core lipids observed in our
denaturation studies. This process mimics aspects of HDL interac-
tions with its receptor, scavenger receptor SR-BI, which mediates
selective uptake of apolar lipids from HDL core at the last step of
reverse cholesterol transport [59,60] (Figs. 1 and 4). Thus, heat-
or denaturant-induced HDL fusion and rupture, accompanied by
apoA-I dissociation, mimic key aspects of metabolic transforma-
tions of plasma HDL during reverse cholesterol transport.
We propose that HDL perturbations by various factors (such as
thermal or chemical denaturation, hydrolysis of various lipids,
cholesterol esteriﬁcation, lipid transfer, receptor interactions,
etc.) shift the balance between the apolar core and the polar sur-
face. To restore the balance, the lipoprotein assembly has a limitedrepertoire of spontaneous responses: to release excess polar moi-
eties from the surface (via protein dissociation) or to compensate
for lack of such moieties (via lipoprotein fusion and, ultimately,
rupture). HDL fusion and rupture involve concomitant repacking
of many protein and lipid molecules and are thermodynamically
irreversible. The rates of these transitions are modulated by kinetic
barriers (Fig. 4) that separate HDL subclasses and decelerate their
spontaneous inter-conversions in vivo [61].2.6. Other lipoproteins are stabilized by free energy barriers
Our stability studies revealed that, similar to HDL, other
lipoprotein classes such as LDL and VLDL are also stabilized by free
energy barriers [62–65]; however, the height of these barriers and
the activation energy is different for different lipoprotein classes.
The underlying morphological transitions are also different,
reﬂecting distinct metabolic transformations that occur in these
lipoproteins in vivo. For example, heat-induced LDL aggregation
and fusion observed in our biophysical studies mimic closely LDL
aggregation and fusion that occur upon LDL retention in the arteri-
al wall [62,63]. These LDL reactions are thought to provide an early
triggering event in atherosclerosis [28].
Another example is thermal denaturation of human plasma
VLDL. Intriguingly, this process involves not only lipoprotein
fusion, rupture and dissociation of exchangeable apos, but also ﬁs-
sion of small apoE-containing HDL-like particles [64,65]. Very simi-
lar apoE-containing HDL are released from VLDL upon hydrolysis of
core lipids during VLDL-to-LDL conversion in vivo [64].
Together, these examples support the idea that various bio-
physical or biochemical perturbations lead to a ﬁnite number of
structural responses in lipoproteins that help restore the balance
between their polar surface and the apolar core. Therefore, we pos-
tulate that lipoprotein remodeling in vitro and in vivo involves
similar structural responses and is modulated by similar kinetic
barriers. Such barriers help explain why lipoprotein classes and
subclasses co-exist in plasma and do not spontaneously converge
into the lowest free-energy state, or the proverbial primordial
soup. At the same time, such barriers help ensure that potentially
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hydrolysis, dissociation of individual protein and lipid molecules,
etc.) are not detrimental to the overall structural integrity of the
lipoprotein assembly.
Kinetic barriers have been proposed to optimize structural sta-
bility and functions of other macromolecules and their assemblies
and protect them against potentially deleterious effects of oxida-
tion, hydrolysis and other post-translational modiﬁcations [66].
Our research has added lipoproteins to the growing list of macro-
molecular complexes whose structural stability and functional
remodeling are modulated by free energy barriers, and has estab-
lished experimental approaches for measuring these barriers
[41,42,44].
2.7. Functional role of structural disorder in HDL
What height of the free energy barriers is optimal for HDL func-
tion? Since HDL perform various functions and undergo multiple
rounds of metabolic remodeling, these dynamic barriers might dif-
fer at different metabolic steps and the balance among them prob-
ably modulates the overall rate of reverse cholesterol transport.
Studies of model and plasma HDL varying in protein and lipid com-
position suggest a general trend: less stable particles tend to be
functionally more efﬁcient [61]. Examples are outlined below,
starting with HDL biogenesis at the ﬁrst step of reverse cholesterol
transport, and ending with the uptake of apolar lipids by HDL
receptor at the last step (Fig. 1).
(i) HDL biogenesis: involves remodeling of plasma membrane by
apoA-I and formation of small discoidal HDL (Fig. 1). Such
remodeling can occur spontaneously in vitro in model lipo-
somes comprised of relatively short-chain phospholipids
(C14 or shorter), which form relatively thin bilayers whose
packing defects, which are maximal at the chain melting
temperature, facilitate protein insertion. Longer-chain phos-
pholipids such as those found in the plasma membrane (18
carbons or longer) form thicker more ordered bilayers. The
remodeling of such bilayers by apoA-I does not occur spon-
taneously at an appreciable rate, and is facilitated by the
lipid transporter ABCA1 in vivo. This ATP-powered trans-
porter pumps lipids from the inner to the outer leaﬂet of
the plasma membrane and thereby perturbs lipid packing
and forms protrusions on the membrane surface [67].
Direct and lipid-mediated ABCA1-apoA-I interactions also
contribute to HDL biogenesis [68]. Although the complex
interactions between apoA-I, ABCA1 and the plasma mem-
brane are far from clear, the perturbed lipid packing prob-
ably contributes to apoA-I insertion into the membrane.
Thus, packing disorder in the lipid bilayer probably aug-
ments apolipoprotein insertion into the membrane and
HDL biogenesis.
Moreover, in vitro studies using various apolipoproteins
clearly showed that reduced structural stability of free pro-
tein accelerates lipoprotein formation [61]. For example,
the rate of lipoprotein formation by the three major isoforms
of apoE correlates inversely with the structural stability of
free protein, apoE4 < apoE3 < apoE2 [5,69]. This inverse cor-
relation probably reﬂects the competition between the ter-
tiary interactions among the protein a-helices and the
protein–lipid interactions. In sum, structural disorder in
the protein and in the lipid bilayer augments formation of
discoidal lipoproteins.
(ii) HDL maturation: is the next metabolic step in reverse choles-
terol transport. At this step, discoidal HDL take up additional
cholesterol from the cells, which is then esteriﬁed via
the LCAT reaction. Cholesterol ester, which is highlyhydrophobic, moves inside the particle forming its apolar
core and converting it into a mature spherical HDL.
Stability and functional studies showed that larger proteins
and longer more fully saturated phospholipids form more
stable discoidal lipoproteins [44,45,61] that are less efﬁcient
acceptors of cell cholesterol and less efﬁcient activators of
LCAT [70,71]. These studies suggest an inverse correlation
between structural stability of discoidal HDL and their func-
tions in cell cholesterol efﬂux and esteriﬁcation [61].
(iii) Functions and stability of mature spherical HDL: show a simi-
lar trend observed in the oxidation studies of plasma HDL
[72]. Interestingly, mild oxidation by various reagents was
shown to destabilize human HDL (i.e. promote apoA-I disso-
ciation and HDL fusion and rupture) as well as improve HDL
function in promoting cholesterol efﬂux from cells. In con-
trast, more extensive oxidation had opposite effects: it stabi-
lized HDL against fusion and impaired HDL ability to
stimulate cholesterol efﬂux from cells [72]. Thus, the inverse
correlation between structural stability and function is not
limited to model discoidal but also extends to plasma sphe-
rical HDL.
One of the important functional determinants of spherical
HDL is the particle size [19]. Epidemiologic studies suggest
that large lipid-loaded HDL2 are more cardioprotective than
their smaller HDL3 counterparts. Stability studies show that
larger HDLs undergo rupture and release of their apolar
lipids more readily than smaller particles [47] (Fig. 3A).
This suggests that reduced stability of HDL2 may contribute
to the preferential receptor-mediated uptake of apolar lipids
from these larger lipid-loaded particles at the ﬁnal step of
reverse cholesterol transport (Fig. 1).
Taken together, these studies illustrate that inverse correlation
between HDL stability and function extends from the ﬁrst to the
last step of reverse cholesterol transport. Since reduced macro-
molecular stability generally promotes local structural ﬂexibility,
we propose that local ﬂexibility of HDL facilitates insertion of
various plasma factors (LCAT, hepatic lipase, phospholipid
and cholesterol ester transfer proteins etc.) whose action displaces
a considerable portion of apoA-I and promotes HDL fusion
[38,55–58,73–75], which is crucial reverse cholesterol transport
[61].
Does this imply that low structural stability of HDL necessarily
beneﬁts cholesterol removal? We think this is unlikely, since dras-
tic destabilization will adversely affect HDL interactions with its
functional partners (e.g. LCAT, CETP, etc.) and promote HDL degra-
dation. Moreover, the rate of HDL turnover depends upon concert-
ed action of many factors which does not necessarily correlate with
HDL stability. Thus, structural stability is just one of the important
determinants of HDL functionality. We propose that HDL stability
must be delicately balanced to maintain the structural integrity
of the lipoprotein assembly yet enable its rapid remodeling and
turnover at key junctures of reverse cholesterol transport.
3. Structural adaptation of HDL proteins to the increasing lipid
load
3.1. Detailed HDL structure remains unknown
Nascent HDL, which are generated in vivo through the interac-
tions of free apoA-I with the plasma membrane and ABCA1 trans-
porter, are generally thought to form discoidal particles 8 nm in
diameter, each containing two copies of apoA-I, although
particles of other sizes containing more copies of apoA-I have also
been reported [76]. In vivo, these particles are converted into
mature spherical HDL with incrementally increasing diameters
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apoA-I [19,77]. Mid-size HDL can also contain several copies of
apoA-II, the second-major HDL protein whose structure and func-
tion remain unclear [78]. ApoA-II is particularly strongly associated
with mature HDL and can hamper their functional remodeling via
the unknownmechanism [51]. As illustrated in Fig. 1, HDL matura-
tion and growth can be accompanied by HDL fusion and disso-
ciation of free apoA-I. Finally, selective uptake of core lipids by
the SR-BI receptor leads to HDL disruption and dissociation of
the remaining apos.
What conformational changes facilitate apoA-I conversion from
lipid-free to HDL-bound state? How does apoA-I confer curvature
to the otherwise ﬂat phospholipid monolayer on the surface of
HDL, which is necessary to encapsulate apolar lipids in its core?
What is the structural ensemble of apoA-I on HDLs of various
shapes and sizes? These questions are important since apoA-I
forms the structural scaffold and the functional ligand on HDL
surface, which confers HDL shape and interacts with many
HDL-associated proteins [11,34].
The answers to these questions are unclear because spatial and
temporal heterogeneity of HDLs makes them resilient to high-
resolution structural studies. However, the wealth of low-resolu-
tion information on model and plasma HDL, combined with the
two available X-ray crystal structures of free N- or C-terminally
truncated apoA-I, allow educated guessing.
3.2. Low- and high-resolution structural studies of apoA-I
ApoA-I has long been known to contain a globular a-helical N-
terminal domain that opens up on the lipid, and a ﬂexible C-termi-
nal tail that initiates lipid binding and aggregation. Low thermody-
namic stability and high aggregating propensity of free apoA-I have
complicated its structural studies. Low-resolution X-ray crystal
structure of the N-terminally truncated protein, D(1–43)apoA-I,
solved by Borhani, Brouillette and colleagues, was proposed to rep-
resent an HDL-bound protein conformation [79]. This structure
revealed an unusual ‘‘horseshoe-shape’’ conformation in which
two highly a-helical protein molecules formed an antiparallelFig. 5. Crystal structure of the C-terminally truncated free apoA-I provides new insight
D(185–243)apoA-I [34] (PDB ID: 3R2P). Two antiparallel dimer-forming molecules are re
induced helical kinks in these two molecules are in register, conferring the semi-circular
contains seven 11/22-mer sequence repeats (numbers in italics). Straight segments repre
length apoA-I on small HDL [88]. The model was derived from the crystal structure in (A
185–243 fragments (red). (C) Proposed interaction mechanism of full-length apoA-I wit
insertion of the hydrophobic ﬂexible C-terminal tails into the membrane are crucial in t
transporter [68]. Figure modiﬁed from [88].dimer. In this dimer, the central 22-mer helical repeat 5 (resides
121–142), as well as the C-terminal repeats 10 (residues 220–
241) were in register. This ‘‘double-belt’’ dimer, with its antiparal-
lel helical arrangement and 5/5 and 10/10 repeat register, provided
an important starting model for understanding apoA-I conforma-
tion on HDL of various shapes and sizes [80].
Protein cross-linking and mass spectrometry studies by
Davidson’s team suggested overall conformational similarity for
apoA-I on HDL disks and spheres. This lead to the development
of the trefoil-tetrafoil models proposing how apoA-I can adapt to
the surface of discoidal and spherical HDL via minimal structural
rearrangements [77,81].
Despite extensive studies by many teams, several important
aspects of the apoA-I structure remained unknown. These included
the solution conformation of free apoA-I, as well as the detailed
conformations of apoA-I, particularly its N-terminal part, on var-
ious HDL. Also, despite signiﬁcant advances in low-resolution
structural studies of apoA-II on HDL [82], the structure–function
relationship in apoA-II remained unclear. Thus, low-resolution
structural and biophysical studies yielded invaluable information
on the overall HDL architecture but fell short of providing a com-
plete picture of the structural ensemble of HDL proteins.
Two recent developments greatly advanced our understanding
of HDL structure–function. First, Phillips, Englander and colleagues
used hydrogen–deuterium mass spectrometry (HX MS) to charac-
terize full-length human apoA-I in solution and on model discoidal
HDL [83,84]. Second, Mei and Atkinson determined the ﬁrst
atomic-resolution X-ray crystal structure of free human C-termi-
nally truncated apoA-I, D(185–243)apoA-I [34]. The hydrophobic
ﬂexible C-terminal tail was truncated to facilitate crystallization.
This truncation had little effect on the rest of the protein structure,
as evident from the agreement between the crystal structure of
D(185–243)apoA-I and the HX MS analysis of full-length apoA-I
in solution [34,83].
The crystal structure of D(185–243)apoA-I was a true eye-
opener that clariﬁed some existing concepts and revealed new
important features. The crystallographic dimer forms a semi
circular arc punctuated by prolines, with diameter d  11 nms into HDL biogenesis. (A) Cartoon drawn to scale shows X-ray crystal structure of
lated via the 2-fold symmetry axis passing through the middle of repeat 5. Proline-
dimer shape whose curvature is commensurate with that of HDL. Fragment 1–184
sent a-helices. Critical Gly residues are indicated. (B) Proposed conformation of full-
) by tightening the Pro-induced kinks, which allows the double-belt closure via the
h the plasma membrane and generation of nascent HDL. Protein dimerization and
his process [34], which is also proposed to involve apoA-I interactions with ABCA1
Fig. 6. Hypothetical molecular mechanism of structural adaptation of apoA-I to the increasing lipid load in HDL during reverse cholesterol transport. Constant (66–184, in
black) and variable regions (1–66, in blue, and 185–243, in red) are indicated. (A) Small nascent HDL (d  8 nm, 2 copies of apoA-I); (B) small mature HDL (d  8 nm, 2 copies
of apoA-I); (C) mid-size mature HDL (d  9.6 nm, 3 copies of apoA-I); (D) large mature HDL (d  11.5 nm, 4 copies of apoA-I). Swing axis that, we propose, connects G65, P66
and G185, G186 hinges is in yellow. Odd copies of apoA-I are proposed to adopt a ‘‘double hairpin’’ conformation (C, bottom). Mid-size human HDL can also carry several
copies of apoA-II as their second-major protein [51] (not shown). Figure modiﬁed from [88].
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tent with the horseshoe-shaped conformation of the N-terminally
truncated protein [34,79], making it crystal-clear how the protein
confers curvature to the lipid monolayer on HDL surface.
Importantly, the antiparallel helical dimers observed in the crystal
structures of the N- and the C-terminally truncated proteins
showed many similarities, including 5/5 repeat register (Fig. 5),
supporting the idea that this register is an inherent property of
apoA-I dimer. The structure of D(185–243)apoA-I also provided a
detailed view of the central opening between the juxtaposed
repeats 5, which probably facilitates LCAT insertion during choles-
terol esteriﬁcation [34]. Moreover, this structure helped under-
stand the action of two putative gain-of-function mutants, apoA-I
Milano and Paris [85], provided the ﬁrst structural basis for under-
standing the misfolding of nearly 20 other mutants that cause
amyloid disease in humans [86,87], and helped understand the
structural and functional role of apoA-II on HDL [51].
3.3. Adaptation of apoA-I structure to HDL of various shapes and sizes
The 2.2 Å resolution crystal structure of free D(185–243)apoA-I,
together with the biophysical information on apoA-I obtained over
the years by many groups, provided the starting model for under-
standing the conformations of the full-length protein in solution
and on HDL [34,88]. For example, the globular helix-bundle confor-
mation of full-length free apoA-I monomer can be obtained from
the crystallographic dimer by swapping the polypeptide chain
around the ﬂexible repeat 5 [34], with the ﬂexible C-terminal tail
loosely folded against the helix bundle [25,89]. Further, the crystal
structure suggests that the ﬂexible C-terminal tails from the two
dimer-forming molecules act in concert to insert into the plasma
membrane and sequester lipids to form nascent HDL [34,88]. In
the resulting small nascent HDL, two copies of apoA-I probably
completely encircle the particle perimeter in an antiparallel double
belt (Fig. 5C).
This and other structural and biophysical information enabled
us to propose the conformational ensemble of apoA-I on various
HDLs (Fig. 6) [88]. To derive it, we used two basic principles.
First, HDL undergoes minimal structural re-arrangement at each
step of metabolic remodeling to minimize kinetic barriers
modulating these steps. Second, such re arrangements involveconformational changes facilitated by Gly-containing ﬂexible
regions: the G56–P66 and G184–G185 hinges, the G39-containing
turn, and G129-containing repeat 5. Further, we assumed that HDL
fusion involves incremental elongation of the apoA-I double belt,
while HDL rupture and release of core lipids involves disruption
of the belt-closing contacts between the N- and the C-termini that
probably form the weakest link in the belt [88].
Fig. 6 illustrates the hypothetical molecular mechanism for
apoA-I adaptation to the increasing lipid load. To elongate the belt,
the N-terminal helix bundle is proposed to sequentially open
around two ﬂexible hinges containing G39 and G65–P66 [34].
We postulate that, to fully close the double belt, this unhinging
must be accompanied by incremental change in resister of the
belt-closing segments near the molecular termini [88]. One way
to accomplish it is via the change in register of the helical repeats,
from 9/9 on the small, to 10/10 on the midsize, to G/G on the large
HDL (the G-repeat encompasses N-terminal residues) (Fig. 6).
Currently, only the 10/10 repeat register on midsize HDL has been
experimentally established, while the others remain hypothetical
[51,80,88].
Another important aspect of the proposed mechanism is the
conformational adaptation of apoA-I to the surface of discoidal
and spherical HDL, which is curved in 1D or 2D, respectively. In
our model, this adaptation occurs via the swing motion of the dou-
ble belt around two hinges, G65–P66 and G185–G186 (Fig. 6).
These hinges split the molecule neatly into two 120-residue
halves, a constant region containing central residues 66–185
(black) and a variable region containing the N- and C-terminal resi-
dues, 1–65 (blue) and 185–243 (red). This swing motion of the two
halves of the double-belt is reminiscent of the trefoil/tetrafoil mod-
el proposed by Davidson’s team [77]. Although their proposed
swing axis was different from ours, the key concept underlying
these two independently derived models is very similar. The argu-
ments in favor of the G65, P66–G185, G186 swing axis and other
experimental evidence supporting our model has been outlined
elsewhere [88].
An interesting idea proposed in the original trefoil/tetrafoil
model is the domain swapping among the double belts [77] where-
by a polypeptide chain segment from one apoA-I molecule rotates
around the central axis to pair with another copy of apoA-I (Fig. 6D,
circular arrow). Such a rotation, which is akin to ﬂipping book
Fig. 7. Hypothetical model of a large nascent HDL that contains more than two
copies of apoA-I. Protein arrangement around the perimeter of a particle containing
four copies of apoA-I in two antiparallel dimers with 5/50 helix register and head-to-
tail dimer packing is illustrated (top view). Other dimer-based models, with N-
terminal segments partially folded back, or monomer-based models with apoA-I in
a double-hairpin conformation (Fig. 6C, bottom) can also be envisioned.
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and 2, 2 and 3, 3 and 4, 4 and 1) into a single framework.
Despite its esthetic appeal, this idea has several caveats. First,
domain swapping can only involve segments of similar shape
and size. Our model suggests that this is only possible on the large
HDL where apoA-I adopts a fully extended helical conformation,
but not on the small or midsize particles where the N-terminal part
is folded back (Fig. 6). Second, domain swapping of a protein bound
to the lipid surface is expected to involve transient disruption of
multiple protein and lipid interactions, which is energetically cost-
ly. Third, experimental studies showed the presence of two compa-
rable-size populations of apoA-I on HDL, one easily exchangeable
and the other tightly bound to the particle [51–54,90]. The pres-
ence of the exchangeable population argues against integration
of multiple copies of apoA-I into a single framework via the domain
swapping. Thus, we believe that such a domain swapping is
unlikely.
We propose that the strongly bound apoA-I is probably the pri-
mary double belt that formed the nascent HDL, whereas the loosely
bound population contains additional protein that adsorbed to the
growing HDL particle at later stages. This ‘‘easy come – easy go’’
population is probably comprised of the monomeric apoA-I that
may adopt a double-hairpin conformation (Fig. 6C). In fact, com-
pared to the dimer, the apolipoprotein monomer has lower activa-
tion energy of dissociation from the lipid surface and hence, is
more readily exchangeable than the dimer [44].
The presence of two distinct populations of apoA-I on HDL is
probably important for HDL function in normal state and in dis-
ease. For example, in acute inﬂammation, nearly 50% of total
apoA-I can be displaced from HDL by serum amyloid A [90].
Intriguingly, this displacement does not greatly alter several func-
tions of acute-phase HDL [90], suggesting that these functions are
determined mainly by the non-exchangeable apoA-I. Thus, we
posit that the non-exchangeable apoA-I, which is the major deter-
minant of HDL structure and function, represents the original dou-
ble-belt dimer, whereas the exchangeable apoA-I serves as an
additional modulator of HDL metabolism.
The models in Figs. 5 and 6 represent useful structure-based
starting points for deriving the conformational ensemble of
apoA-I on HDL, but do not represent a complete ensemble. For
example, they can accommodate but do not explicitly account for
the ‘‘looped belt’’ model in which apoA-I segment around residue
140 adopts a dynamic conformation that comes on and off the lipid
[91,92]. Also, our models can accommodate other HDL stoichiome-
tries, including nascent HDL containing three, four or more copies
of apoA-I. Fig. 7 shows a hypothetical model of one such particle
containing four copies of apoA-I organized as two head-to-tail
dimers.
3.4. Possible role of apoA-II in HDL structure and dynamics
ApoA-I and apoA-II comprise approximately 70% and 20% of
HDL protein content, respectively, and are the major determinants
of HDL structure and function. ApoA-II is an enigmatic protein that
modulates reverse cholesterol transport via the unclear mechan-
isms. Human apoA-II forms a disulﬁde-linked homodimer that is
strongly bound to mature HDL [49,78,82]. These HDL are termed
HDL(A-I/A-II) as they contain both apoA-I and apoA-II. Although
the structural and functional role of apoA-II is subject of debate,
the consensus is that apoA-II can hamper metabolic remodeling
of HDLs and modulate their metabolism indirectly by inﬂuencing
the apoA-I conformation [49,78].
We proposed a structural model explaining why human apoA-II
circulates almost exclusively on the mid-size HDL and why it ham-
pers HDL remodeling in vivo [51]. Brieﬂy, in our model of small
spherical HDL (Fig. 6B), the variable region of the apoA-I doublebelt provides the 2D curvature and the adequate surface coverage,
leaving no room for apoA-II. On midsize HDL (Fig. 6C), the variable
region of apoA-I swings out of plane of the double belt, vacating
the surface for binding additional protein molecules such as
apoA-I monomer (Fig. 6E) or apoA-II homodimer. The latter con-
sists of two 77-residue molecules disulﬁde-linked via Cys6, which
are probably arranged in an antiparallel double hairpin [82]. The
length of the apoA-II homodimer matches best the variable region
of apoA-I in the midsize double belt (85 residues, blue and red
segments in Fig. 6C). This explains the preference of apoA-II for
the midsize human plasma HDL. Notably, apoA-II is too short to
match the fully expanded variable or constant half of apoA-I on
large HDL (120 residues, Fig. 6D), which helps explain why
apoA-II is not found on large plasma HDL(A-I/A-II). Moreover, this
structural mismatch suggests that apoA-II on HDL(A-I/A-II) ham-
pers conformational change in apoA-I, from the relatively compact
midsize to the large fully expanded double belt [49].
In sum, our structural model suggests that apoA-II decelerates
the remodeling of the midsize HDL(A-I/A-II) into large lipid-loaded
particles, which are the preferred substrates for HDL receptor.
Therefore, we posit that apoA-II generates a structurally and func-
tionally inert population of plasma HDL(A-I/A-II) with increased
lifetime but reduced rate of cholesterol transport [51]. This inert
population can be viewed as a buffer that maintains HDL quantity
but probably not its quality. This hypothesis is consistent with the
observation that humans lacking apoA-II show normal lipoprotein
proﬁle and susceptibility to atherosclerosis [93]. The presence of
such inert populations of human plasma HDL may contribute to
the complex relationship between the plasma levels of ‘‘good
cholesterol’’ and cardioprotection.
4. Prediction of intrinsic disorder in HDL proteins
Large secondary and/or tertiary structural changes induced in
the exchangeable apolipoproteins upon lipid binding, combined
with the molten globule-like properties of these proteins in solu-
tion [9,35–37] suggest that free apos are fully or partially intrinsi-
cally disordered. Computational analysis supported this idea.
Amino acid sequences of selected human apos were analyzed by
using two disorder prediction metaservers, D2P2 [94] and
GenSilico [95]. The detailed results will be reported elsewhere.
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with each other and indicated increased disorder in apos as com-
pared to typical globular proteins. Thus, human apoA-I and apoA-
II were predicted to have global disorder tendency circa 0.4 by
GenSilico and have over 50% of disordered residues by PONDR
VSL2 [96], which clearly classiﬁes them as intrinsically disordered.
Importantly, the disorder prediction results agreed with the struc-
tural studies of apos by X-ray crystallography, HX MS and other
methods. For example, regions of apoA-I that form the helix bundle
in solution were predicted to be largely ordered, while the predict-
ed disorder was concentrated largely in the central part encom-
passing ﬂexible repeat 5, and in the C-terminal tail whose
ﬂexibility has been established experimentally [34,83]. Notably,
the amyloidogenic segments in apoA-I were predicted to be
ordered, in agreement with our recently proposed molecular
mechanism of apoA-I misfolding in amyloidosis [87]. In sum, the
disorder prediction methods classify apoA-I and other exchange-
able apos as intrinsically disordered, which agrees with high struc-
tural ﬂexibility characteristic of this protein family.
5. Concluding remarks
This review illustrates how combined biophysical and struc-
tural approaches help elucidate functional properties of dynamic
macromolecular assemblies such as HDL. The kinetic origin of
HDL stability, which is critical for maintaining discrete HDL sub-
classes (Fig. 4) and thereby modulating reverse cholesterol trans-
port (Fig. 1), is ultimately rooted in HDL structure (Figs. 5 and 6).
We propose that large discrete structural changes in HDL assembly
(such as the incremental opening of the apoA-I double belt upon
increasing lipid load (Fig. 6C and D), or the dissociation of apoA-I
monomer and lipoprotein fusion (Fig. 3E)) involve large activation
energy, Ea, and large free energy barriers, DG⁄. In contrast, con-
tinuous structural changes (such as the gradual swing motion of
a double-belt segment to accommodate apolar lipids accumulating
in HDL core during maturation (Fig. 6B)) are expected to proceed
smoothly, unencumbered by high kinetic barriers. The combina-
tion of the continuous and the discrete conformational changes
probably accounts for HDL heterogeneity, with multiple kinetic
barriers separating distinct subclasses of plasma HDL varying in
their composition and functional properties (Fig. 4).
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